Periodontitis {#s1}
=============

Periodontitis is an inflammatory disease, which affects tissues surrounding and supporting the teeth. It occurs in response to dysbiotic periodontal microbiota accumulating as a bacterial plaque on the tooth surface below the gum line that triggers a chronic inflammatory reaction (Graves et al., [@B39]). Dysbiotic bacteria, also called pahtobionts, are commensal microorganisms that under conditions of disrupted homeostasis have a potential to deregulate inflammatory responses and cause disease (Hajishengallis and Lamont, [@B48]). Chronic periodontitis is one of the most prevalent inflammatory diseases of humans and in its most severe form it is the sixth most prevalent disease affecting 11.2% of the global population and representing a substantial public health burden (Kassebaum et al., [@B65]). Risk factors for developing periodontal disease (PD) are genetic factors, cigarette smoking, diabetes, osteoporosis, age, and infections with red complex bacteria. Red complex bacteria is a group of three species including *Porphyromonas gingivalis, Treponema denticola*, and *Tannerella forsythia*, which presence is strongly associated with each other and disease sites (Socransky et al., [@B120]; Van Dyke and Sheilesh, [@B125]).

According to the well-accepted polymicrobial synergy and dysbiosis model, the host immune response is initially manipulated by keystone pathogens (e.g., *P. gingivalis*) with the help of accessory pathogens and is subsequently over-activated by pathobionts (Hajishengallis et al., [@B50]). This concept of keystone species is derived from basic ecological studies. A keystone pathogen is a microorganism that exerts a huge impact on the microbiotic community, while being present at very small quantity (Darveau et al., [@B23]). Another hypothesis on the development of the oral diseases is based on the imbalance in the oral microflora caused by ecological stress, causing an enrichment of some periodontal pathogens (Marsh, [@B83], [@B84]). This "Ecological Plaque Hypothesis" is supported by the fact that expressed by *P. gingivalis* gingipains degrade collagen (Houle et al., [@B59]) and therefore enrich the growth environment in peptides favoring growth of the red complex bacteria. A futile attempt of the host to eradicate periodontopathogens fuels a chronic inflammatory reaction in the infected periodontium. In genetically susceptible hosts, this leads to a dissolution of periodontal ligament, alveolar bone resorption, deep periodontal pocket formation, and eventual tooth loss (Reynolds and Meikle, [@B110]). The presence of keystone pathogens can cause deregulated inflammation and disease without apparent predispositions (Hajishengallis, [@B45]).

Neutrophils\' functions and survival {#s2}
====================================

Neutrophils, also called polymorphonuclear leukocytes or, in short, PMNs, are the most abundant white blood cells in the gingival crevice and periodontal pocket, where they play a crucial role in the innate immunity response against bacterial infection and thus are responsible for the maintenance of homeostasis in periodontal tissues. PMNs are produced in the bone marrow in large amounts, meaning 5^−10^ × 10^10^ cells per day, and are released into the peripheral blood as terminally differentiated and fully competent effector cells (Borregaard, [@B12]). This is in contrast to adaptive immunity, where T and B lymphocytes require activation and proliferation steps in secondary lymphatic organs in order to become effector cells (Segal, [@B116]; Nathan, [@B95]).

Neutrophils are the most efficient phagocytes and they eliminate pathogens by a variety of means, which are either oxygen-dependent (oxidative burst) or oxygen-independent (anti-microbial peptides and lytic or proteolytic enzymes; Figure [1](#F1){ref-type="fig"}). Neutrophil priming by pro-inflammatory signals recruits the cytosolic NADPH oxidase complex to the phagosome membrane which leads to the generation of reactive oxygen species (ROS). The respiratory burst can disrupt bacterial phospholipid bilayers, degrade or inactivate proteins, and trigger DNA damage (Segal, [@B116]; Nauseef, [@B96]). Importantly, these processes can occur in hypoxic periodontal pockets, where oxygen concentration is as low as 1--3% (Loesche et al., [@B76]). In order to meet high-energy requirements, neutrophils engage glycolysis, which is a huge advantage under hypoxic conditions present in periodontal pockets. This unique strategy is in contrast to ATP production mechanisms in most cells in the human body (Borregaard and Herlin, [@B13]). Non-oxidative microbial killing relies on the contents of three types of cytoplasmic granules, namely: azurophilic (primary) granules, specific (secondary) granules, and gelatinase granules. Neutrophil activation triggers granule fusion with phagosomes. These granules deliver antimicrobial proteins and peptides, such as azurocidin, cathelicidin, α-defensins, lysozyme, lactoferrin, elastase, and cathepsin G, that disrupt bacterial cell envelope, destroy peptydoglican, degrade proteolytic bacterial virulence factors, or sequester iron (Soehnlein, [@B121]). Beside this antimicrobial arsenal, PMNs can additionally form neutrophil extracellular traps (NETs), which are composed of decondensed nuclear or mitochondrial DNA associated with antibacterial (granule) enzymes, peptides, and histones. These extracellular structures are designed to disable invading pathogens and elicit proinflammatory responses (White P. C. et al., [@B129]). PMNs have the shortest lifespan of all immune cells, i.e., around 24 h under the steady state, while for example T lymphocytes may stay alive for weeks. Normally, neutrophils circulate in the blood for 6--12 h and then home to the bone marrow, spleen or liver where they undergo apoptosis. Subsequently, they are phagocytosed by Kupffer cells in the liver or by red pulp macrophages in the spleen (Summers et al., [@B122]; Vier et al., [@B126]). This short life-span of neutrophils is tightly controlled by apoptosis, which is a form of programmed cell death relying on enzymes of the Caspase family of endopeptidases. It is a critical process involved in embryonic development or the maintenance of tissue homeostasis in the adult organism. Its deregulation is implicated in different pathologies, including cancerogenesis or disorders of the immune system (Sochalska et al., [@B118]; Tuzlak et al., [@B124]). Apoptosis is a very precise process controlled by the Bcl-2 family proteins, which encompasses many pro- and anti-apoptotic proteins that form homo- or heterodimers in order to promote or prevent apoptosis (Sochalska et al., [@B119]). The pro-survival family members, i.e., Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1, share four BH (Bcl-2 homology) domains and beside A1, they possess a transmembrane domain at the C-terminal end. They prevent apoptosis by sequestering (inhibiting) pro-apoptotic BH3-only proteins, such as Bim, Bmf, Noxa, Puma, Bid, Bad, Bmf, and HRK. The BH3-only proteins act as sentinels for various stress stimuli, such as DNA damage, growth factor deprivation, ER-stress or oncogenic transformation (Tuzlak et al., [@B124]). Moreover, after successful phagocytosis of invading bacteria, neutrophils undergo apoptosis, a very important step for the resolution of inflammation, which is called phagocytosis-induced cell death (PICD). Exposure of the cell to an apoptotic stimulus frequently engages BH3-only proteins, either transcriptionally or translationally, which allows them to either directly (Bim and tBid) or indirectly (all BH3-only) activate the pro-apoptotic effector proteins Bax/Bak (Czabotar et al., [@B20]; Garcia Saez and Villunger, [@B36]).

![**Immune responses to pathogens**. During an infection with pathogens, for example *E. coli*, lipopolisaccharide enhances the secretion of chemotactic IL-8 and stimulates the upregulation of E- or P-selectins expression on gingival endothelial cells (GECs). Selectins facilitate neutrophils adhesion during transmigration as they interact with PSGL-1 expressed on PMNs. Moreover, the presence of microbes and their particles activates the complement cascade. C3a and C5a are anaphylatoxins with a strong chemotactic and pro-inflammatory potential. IgG and IgM antibodies or C3b recognize bacterial antigens and opsonize invading pathogens thus facilitating bacterial phagocytosis. LPS activates the TLR4 signaling pathway in recruited neutrophils, eliciting strong inflammatory responses designed to inactivate the pathogen. Inflammatory responses include the production of reactive oxygen species, secretion of pro-inflammatory cytokines and antimicrobial enzymes or peptides, such as cathepsin G, elastase, cathelicidins or defensins. After a successful bacterial clearance, neutrophils undergo apoptosis, an essential process triggering the resolution of inflammation.](fcimb-07-00197-g0001){#F1}

However, in the context of *P. gingivalis* infection, neutrophils are unable to phagocyte this periodontopathogen present within the huge biofilm structure. During phagocytosis of something too big to be ingested, a process so-called "frustrated phagocytosis," they generate reactive oxygen species and secrete enzymes in order to destroy the pathogen. Unfortunately, these secreted weapons concomitantly contribute to the inflammatory destruction of gingival tissues and alveolar bone (Scott and Krauss, [@B115]).

Neutrophils in periodontitis {#s3}
============================

On one hand, functional neutrophils are indispensable for the maintenance of periodontal health, as illustrated by several neutrophil genetic defects, including neutropenias (Ryder, [@B111]; Wiesmeier et al., [@B131]), LAD-I Syndrome (Leukocyte Adhesion Deficiency Type I; Moutsopoulos et al., [@B91]) or Papillon-Lefevre syndrome (Eick et al., [@B32]), which are associated with periodontal phenotype. On the other hand, neutrophilia, which is the accumulation of neutrophils and their histotoxic cargo in the tissue, has been clinically linked to cystic fibrosis and meningitis and may also account for the currently unknown etiology of inflammatory bowel disease, Crohn\'s disease, ulcerative colitis, or periodontal disease (Hajishengallis et al., [@B52]; Koedel et al., [@B67]; Levine and Segal, [@B73]; Gifford and Chalmers, [@B37]; Prat et al., [@B103]). Thus, tight control of neutrophil functions and survival after bacterial clearance by induction of apoptosis, immune tolerance and resolution of inflammation, exert protective effects toward the host tissues against inflammatory tissue damage. A failure to properly regulate neutrophil abundance and turnover directly contributes to the pathogenesis of periodontitis and current literature implicates neutrophils as the main immune cell type responsible for periodontal disease progression (Hajishengallis et al., [@B53], [@B50]; Scott and Krauss, [@B115]).

A hyper-reactive neutrophil phenotype is considered to play a central function in the periodontal disease (Chapple and Matthews, [@B18]; Scott and Krauss, [@B115]; Hajishengallis and Lamont, [@B49]) and, importantly, many systemic inflammatory diseases are associated with periodontitis, including cardiovascular disease, rheumatoid arthritis and diabetes type 2. As such, "hyper-inflammation" may represent one casual mechanism by which periodontitis contributes to co-morbidity (Hatanaka et al., [@B55]; Yasunari et al., [@B133]; Koziel et al., [@B69]).

Periodontitis patient-derived neutrophils {#s4}
=========================================

A chronic type of the periodontal disease is frequently associated with *P. gingivalis* infection (Guentsch et al., [@B42]). As neutrophil influx into periodontal pockets is strongly induced during such infections, several studies analyzed the functions and survival of periodontitis patient-derived neutrophils. Patients suffering from PD showed overly increased numbers of neutrophils in the oral cavity (Bender et al., [@B9]). Accordingly, one microarray study characterized neutrophil transcriptome changes at the site of inflammation (the oral cavity) and compared the gene expression in the periphery in healthy and PD subjects. The only significant changes were found in the "apoptosis" cluster (Lakschevitz et al., [@B72]). Another study revealed that GM-CSF-dependent neutrophil apoptosis was diminished in periodontitis biopsies, as analyzed by TUNEL staining. Moreover, accumulation of GM-CSF and TNF-α in gingival tissue sections was noted in the majority of diseased sites (Gamonal et al., [@B35]). Furthermore, functionality of tissue-derived and peripheral blood neutrophils from PD patients was deregulated. These PMNs produced higher baseline levels of ROS and elastase (Matthews et al., [@B85]; Guentsch et al., [@B42]; Aboodi et al., [@B1]; Damgaard et al., [@B21]) and secreted more pro-inflammatory cytokines, namely IL-8, IL-6, IL-1β, and TNF-α (Ling et al., [@B75]). Additional challenge of patient-derived neutrophils with *P. gingivalis* augmented the secretion of elastase and pro-inflammatory cytokines (Guentsch et al., [@B42]; Ling et al., [@B75]). Moreover, further exposure of PMNs to either *P. gingivalis-* or *E. coli*-derived LPS enhanced ROS generation and cathelicidin (LL-37) secretion. Similar hyper-activation of neutrophils was noted upon FcɤR engagement and treatment with either GM-CSF or phorbol ester (PMA; Johnstone et al., [@B64]; Matthews et al., [@B85]; Guentsch et al., [@B42]; Mariano et al., [@B82]). In contrast, reduced production of nitric oxide (NO) by peripheral PMNs from PD patients was noted (Mariano et al., [@B82]), which may actually contribute to *P. gingivalis* persistence in the gingival tissue. Importantly, a potential oral-systemic inflammatory activation loop (a self-driving sequence of events) was suggested to operate in patient-derived neutrophils. Analysis of serum isolated from aggressive and chronic periodontitis patients revealed elevated systemic antibodies to *P. gingivalis* (Guentsch et al., [@B42]), while plasma from periodontal patients was more efficient in neutrophil priming to fMLP and directly induced the oxidative burst (Dias et al., [@B28]). Interestingly, this excessive neutrophil activation could be abolished by antibodies neutralizing IL-8, GM-CSF, or IFN-α (Dias et al., [@B29]). Interestingly, elevated NETs release was noted in patients suffering from gingivitis, but no differences were observed in peripheral neutrophils isolated from periodontitis patients. However, NETs degradation by plasma was significantly reduced in periodontitis patients, what might contribute to the chronic inflammation, exaggerated inflammatory responses and tissue destruction observed in PD patients. Importantly, the authors noted that a non-surgical periodontal treatment restored full plasma capacity (Cooper et al., [@B19]; White P. et al., [@B130]). These patient data demonstrated that chronic periodontitis is associated with accumulation in the gingiva of hyper-active neutrophils, which exhibit an elevated release of pro-inflammatory cytokines, ROS, and anti-bacterial enzymes and show defects in apoptosis. Strikingly, *P. gingivalis*-derived LPS might be found in the bloodstream in over 50% of periodontitis patients, what clearly might modulate neutrophil and other white blood cells responsiveness (Deleon-Pennell et al., [@B27]). This deregulation of leukocyte function could modulate not only local, but also systemic inflammatory-immune responses and influence the risk and severity of periodontitis-associated systemic inflammatory diseases. Therefore, many studies have been devoted to elucidate molecular mechanisms underlying such aberrant functions and prolonged survival of neutrophils in the context of *P. gingivalis* infection.

Immune host responses in mouse models of periodontal disease and their limitations
----------------------------------------------------------------------------------

Keeping in mind that studies of periodontitis in humans are burdened with some limitations due to variables that are difficult to control among patients, animal models enable studying development, and progression of periodontal disease in a precise and controlled manner. Moreover, genetically modified mice allow to uncover defined molecular aspects of periodontitis for example involvement of specific immune cell types or signaling pathways in pathogenesis of periodontal disease.

The localized injection of periodontal pathogen *P. gingivalis* or its component into the palatal gingival tissue, oral gavage or ligature models are very convenient mice models of periodontitis. These models are characterized by periodontal tissue destruction as well as inflammation as measured by increased expression of inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, which are typical hallmarks of periodontal disease observed in patients (Adamowicz et al., [@B2]; Saadi-Thiers et al., [@B112]; de Molon et al., [@B25]; Maekawa et al., [@B80]). Importantly, it was reported that the ligature model and injection of heat-killed *P. gingivalis* model were the most representative of periodontal disease in humans, whereas the oral gavage models were not effectively inducing periodontitis under the experimental conditions (de Molon et al., [@B26]). Thus, certainly some of these *in vivo* mouse models are burdened with limitations. Nevertheless, analysis of for example periodontitis induced by ligatures (either previously incubated with *P. gingivalis* or not) or oral gavage application of *P. gingivalis* strain ATCC 33277, revealed elevated serum levels of IL-1β and IL-6 (Saadi-Thiers et al., [@B112]). These results clearly indicated that *P. gingivalis* sustained periodontal inflammation. However, it is difficult to state which particular cells are responsible for this effects. Especially that pro-inflammatory cytokines such as IL-1β, IL-6, or TNF-α are produced by a variety of immune cell types (Arango Duque and Descoteaux, [@B4]).

The best mouse model, which allows analysis of specific immune cell types responsible for *P. gingivalis*-mediated inflammation is the mouse chamber model. This model involves injectable inoculation of bacteria into the lumen of a subcutaneously implanted titanium-coil chamber is better to pinpoint which particular cell types promote inflammation. Strikingly, over 95% of recruited cells to the chambers are Ly6G^+^ leukocytes (neutrophils). Therefore, reported by Maekawa and colleagues accumulation of pro-inflammatory mediators by in the fluid aspirated from chambers as measured by levels of IL-1β, IL-6, TNFα, or IL-17 was distinctly due to neutrophils activation (Maekawa et al., [@B80]). Thus, this chamber mouse model clearly confirmed that *P. gingivalis* triggers neutrophils inflammatory responses at the site of infection. Nevertheless, these *in vivo* results were validated using either ATRA differentiated HL-60 neutrophils or neutrophils isolated from human blood (Maekawa et al., [@B80]). Therefore, results obtained *in vivo* during analysis of mouse models of periodontitis need to be further verified *ex vivo* or *in vitro*.

Another possibility to overcome obstacles during analysis of actual cell types responsible for *P. gingivalis*-mediated inflammation is visualization by confocal microscopy. Adamowicz and colleagues quantified co-localization of infiltrating Ly6G^+^ neutrophils and pro-inflammatory IL-17 cytokine expression in periodontal tissues in *P*. *gingivalis*--induced periodontal bone loss model, clearly showing neutrophil contribution to periodontal inflammation (Adamowicz et al., [@B2]).

In order to pinpoint contribution of the specific immune cells in development and progression of periodontitis genetically modified mice deficient in leukocytes or lymphocytes were analyzed. For example it was shown that mice, which failed to develop MHC class II-reactive CD4^+^ T cells, presented with significantly reduced bone loss. Of note, analysis of mice devoid of NK T cells or CD8^+^ T cells did not protect mice from periodontitis (Baker et al., [@B8]). However, to our best knowledge, impact of neutrophils ablation on periodontal disease development and progression was not analyzed in any of mouse models of periodontitis. Instead, it was reported by Hajishengallis that loss of neutrophil infiltration inhibited disease development (Eskan et al., [@B34]). Mice deficient in Del-1, a negative regulator of neutrophil LFA-1-dependent recruitment to periodontium, exhibited enhanced neutrophil infiltration and IL-17-mediated inflammatory bone loss. In opposite, other authors described that IL-17-mediated neutrophil recruitment was critical in protection against *P. gingivalis*-induced alveolar bone loss in a mouse model (Yu et al., [@B134]). Along the same lines, other authors noted that neutrophil infiltration as well as CD45^+^ B lymphocytes was beneficial in mice infected with *P. gingivalis* (Settem et al., [@B117]). Importantly, IL-17 produced by Th17 cells themselves can drive periodontal bone loss in chronic *P. gingivalis* infections (Moutsopoulos et al., [@B90]). In chronic settings neutrophils themselves can also become a source of IL-17, leading to IL-17-dependent bone loss (Hajishengallis and Hajishengallis, [@B44]). Therefore, the complex role of leukocytes, lympohocytes, and IL-17 (Th17) in periodontitis remind to be determined.

Nevertheless, these results indicated that mouse models are certainly very useful tools in analysis of *P. gingivalis*-mediated periodontal inflammation and *in vivo* analysis contribute to development targeted therapeutics modulating inflammatory cascades regulated by complement (Hajishengallis and Lambris, [@B47]), GSK-3 (Adamowicz et al., [@B2]), regulatory T cells (Glowacki et al., [@B38]), and neutrophils (Eskan et al., [@B34]).

Corruption of neutrophils by *Porphyromonas gingivalis* {#s5}
=======================================================

*P. gingivalis* has developed a variety of mechanisms in order to overcome neutrophil-mediated killing and sustain inflammation, which allows colonization and contributes to tissue damage. This periodontopathogen utilizes several virulence factors that manipulate neutrophils recruitment, survival, and functions at the site of infections. This review will focus on virulence factors involved in the subversion of neutrophils, namely serine phosphatase (SerB), fimbriae, gingipains (RgpA, RgpB, and Kgp), *P. gingivalis* peptidyl arginine deiminase (PPAD), lipopolysaccharide (LPS), and its component (lipid A) (summarized in Table [1](#T1){ref-type="table"}).

###### 

***P. gingivalis* virulence factors involved in the manipulation of neutrophil immune responses**.

  **Virulence factor**                                    **Action**                                                                                                                                                      **Consequences**                                                                                                                   **References**
  ------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  Ser B (serine phosphatase)                              Dephosphorylation of Ser536 of NFκB subunit p65                                                                                                                 Suppression of IL-8 production by GECs (so-called chemokine paralysis); abolished PMNs recruitment                                 Madianos et al., [@B79]; Bainbridge et al., [@B7]; Takeuchi et al., [@B123]
  LPS                                                     TLR2 activation and cross-talk with C5aR inhibits the Myd88 pathway while the Mal-PI3K pathway is induced                                                       Abolition of the Myd88-dependent antimicrobial response and PI3K-mediated phagocytosis; activation of Mal-dependent inflammation   Murray and Wilton, [@B93]; Darveau et al., [@B24]; Liang et al., [@B74]; Maekawa et al., [@B80]; Olsen and Hajishengallis, [@B97]
  LPS with penta-acylated lipid A                         TLR4 agonist; pro-inflammatory potential; produced during low hemin availability                                                                                Increased expression of E-selectins; enhanced PMNs recruitment; impairment of immune tolerance; inhibition of PMNs apoptosis       Dixon and Darveau, [@B30]; Al-Qutub et al., [@B3]; Bainbridge et al., [@B6]; Reife et al., [@B109]; Berezow et al., [@B10]; Zaric et al., [@B135]
  LPS with tetra-acylated lipid A                         TLR4 antagonist; anti-inflammatory potential; produced during high hemin availability                                                                           Suppression of E-selectins expression; inhibition of PMNs recruitment                                                              Dixon and Darveau, [@B30]; Al-Qutub et al., [@B3]; Bainbridge et al., [@B6]; Reife et al., [@B109]
  Kgp (Lys-specific gingipain)                            Degradation of IgG1, IgG3; TREM-1 degradation                                                                                                                   Inhibition of opsonization and phagocytosis; Anti-inflammatory effect                                                              Vincents et al., [@B127]; Guentsch et al., [@B40]
  Rgps (Arg-specific gingipains)                          Increased expression of TREM-1 and PAR2; shedding of sTREM-1                                                                                                    Elevated production of pro-inflammatory cytokines; pro-inflammatory effects                                                        Lourbakos et al., [@B77], [@B78]; Bostanci and Belibasakis, [@B14]; Bostanci et al., [@B16]
  High gingipain levels, Pg-bound enzymes                 Degradation of IL-8 (72aa); proteolysis of TNF-α by Rgp                                                                                                         Abolished IL-8 dependent chemotaxis and ROS production by PMNs; diminished inflammation; chemokine paralysis                       Darveau et al., [@B22]; Mikolajczyk-Pawlinska et al., [@B89]
  Low gingipain levels, secreted enzymes                  Selective cleavage of IL-8~77aa~ results in the generation of a truncated, hyper-active IL-8~69aa~ variant                                                      Pro-inflammatory effects; intensified PMNs recruitment and respiratory burst                                                       Dias et al., [@B28]
  Rgps---initial stages of infection, secreted enzymes    Selective cleavage of C3 and C5 complement factors and generation of active C3a and C5a; induction of C5aR and TLR2 signaling pathways cross-talk (see above)   Induced PMNs chemotaxis; elevated production of pro-inflammatory cytokines and ROS                                                 Wingrove et al., [@B132]; Popadiak et al., [@B98]; Guo et al., [@B43]
  Rgps---advanced stages of infection, Pg-bound enzymes   Degradation of C3 and C5 complement factors                                                                                                                     Anti-inflammatory effects                                                                                                          Popadiak et al., [@B98]; Guo et al., [@B43]
  Kgps                                                    Cleavage of C5aR; C4BP capture on the bacterial surface                                                                                                         Inhibited MPO release; suppression of the formation of the complement membrane attack complex                                      Jagels et al., [@B62],[@B63]; Potempa et al., [@B102]
  Ruberythrin                                             Protection from oxidative stress                                                                                                                                Pro-inflammatory effects; enhanced PMNs recruitment; resistance to reactive nitrogen species-mediated PMNs killing                 Mydel et al., [@B94]
  PPAD                                                    C5a citrullination                                                                                                                                              Reduced pro-inflammatory potential of anaphylatoxin; protection from PMNs-mediated killing                                         Maresz et al., [@B81]; Bielecka et al., [@B11]
  FimA Fimbriae                                           Increased IL-8 production; activation of TLR2 signaling and the CD11b-CD18 integrin pathway                                                                     Pro-inflammatory effects; intensification of PMNs chemotaxis, secretion of pro-inflammatory cytokines, and phagocytosis            Harokopakis and Hajishengallis, [@B54]; Sahingur et al., [@B113]; Wang et al., [@B128]

PMNs deregulation by SerB
-------------------------

Serine phosphatase is an enzyme secreted by *P. gingivalis* that modulates inflammatory responses, as it was shown to inhibit IL-8 production by gingival epithelial cells through the dephosphorylation of serine S536 of p65 NF-κB subunit. This subsequently abolished PMNs recruitment and gave *P. gingivalis* enough time for colonization of periodontal pockets (Figure [2](#F2){ref-type="fig"}). Such insidious manipulation of cell signaling protected this periodontopathogen and bystander bacteria from neutrophil killing during the initial stages of infection. Consequently, SerB expression enhanced alveolar bone resorption in experimentally induced periodontitis in rats (Madianos et al., [@B79]; Bainbridge et al., [@B7]; Takeuchi et al., [@B123]). This implies that manipulation of NF-κB signaling by SerB hinders PMNs recruitment and bacterial clearance in the periodontium and therefore is involved in a pathogenic mechanism referred to as a local chemokine paralysis.

![**Manipulation strategies of neutrophils and the immune system by *P*.*gingivalis* at the initial phase of infection**. During the initial phase of an infection with the keystone pathogen *P. gingivalis* (Pg) secretes serine phosphatase (SerB), inhibiting IL-8 production. At the same time, a tetra-acylated lipid A variant of *P. gingivalis* LPS suppresses the expression of L- and P-selectins on gingival epithelial cells. These manipulation strategies hinder neutrophil recruitment, giving periodontal pathogens enough time for colonization of periodontal pockets.](fcimb-07-00197-g0002){#F2}

PMNs deregulation by LPS
------------------------

Toll-like receptors (TLR) engagement, neutrophil recruitment to the site of inflammation, pro-inflammatory cytokine release, and subsequent elimination of bacteria by PMNs are essential mechanisms of the host immune response against infection. However, after the bacterial clearance, several processes need to be engaged to prevent inflammatory tissue destruction, including the induction of immune tolerance and removal of apoptotic neutrophils from the site of infection. They contribute to the control of the host\'s defense and trigger resolution of inflammation (Bratton and Henson, [@B17]; McCracken and Allen, [@B86]). Lipopolysaccharide (LPS), also known as endotoxin, is a fundamental structural element of the cell envelope of gram-negative bacteria and it is able to elicit appropriate host innate responses. LPS is composed of three elements, namely O-antigen, core polysaccharide, and lipid A. The latter is responsible for the toxicity of Gram-negative bacteria and consists of di-glucosamine with two phosphate moieties at both 1′- and 4′-positions of the disaccharide backbone, where acyl chains are attached (Kumada et al., [@B71]; Raetz et al., [@B106], [@B105]). However, *P. gingivalis* can deceitfully modify its lipid A structure due to both dephosphorylation and deacylation in order to manipulate host immune responses and promote chronic inflammation (Dixon and Darveau, [@B30]; Al-Qutub et al., [@B3]; Reife et al., [@B109]). When considering the heterogeneous acylation patterns of *P. gingivalis* lipid A, two variants are predominant, namely tetra-acylated and penta-acylated. Strikingly, these two variants were described to induce opposing host responses. The penta-acylated lipid A activated TLR4 (Toll-like receptor 4) signaling, whereas tetra-acylated lipid A variant had antagonistic effects against TLR4. Importantly, these changes in acylation were dependent on microenvironmental conditions. In particular, when bacteria were grown in low hemin conditions, LPS consisted of phosphorylated, penta-acylated lipid A structure, which exerted weak LPS agonistic effects. Whereas, during high hemin availability, mimicking an inflammatory condition, phosphorylated penta-acylated lipid A was converted into non-phosphorylated tetra-acylated lipid A, and exhibited an antagonistic activity (Al-Qutub et al., [@B3]). Moreover, tetra-acylated version of *P. gingivalis* lipid A was shown to inhibit E-selectin expression, while penta-acylated lipid A variant had a stimulatory effect (Reife et al., [@B109]). Therefore, *P. gingivalis* can exert opposing effects on the expression of this adhesion molecule expressed on endothelial cells, which impairs neutrophil transmigration during inflammation (Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}).

![**Manipulation strategies of neutrophils and the immune system by *P*.*gingivalis* at the later phase of infection**. During a later phase of the infection *P. gingivalis* releases a penta-acylated LPS variant leading to the increased expression of L- and P-selectins on GECs and enhanced production of IL-8. This strongly stimulates neutrophil chemotaxis and transmigration to the site of infection. Moreover, P.g.-derived LPS and fimbriae strongly stimulate neutrophil pro-inflammatory and anti-bacterial responses, such as the secretion of reactive oxygen species and pro-inflammatory cytokines, and the production of anti-microbial peptides and enzymes. An elevated secretion of these anti-bacterial molecules results in gingival tissue destruction, while many virulence factors secreted by P. gingivalis protect this periodontopathogen from the consequences of hyper-inflammation. The keystone pathogen is protected from oxidative stress, as it expresses ruberythrin (Rbr) protein. Additionally, the expression of Lys-specific gingipains degrades immunoglobulins at the hinge region, and, coupled with the activation of the TLR2 signaling pathway (by LPS), abolishes bacterial opsonization and phagocytosis. Also, gingipains manipulate anti-bacterial responses by deregulating the complement cascade and IL-8-mediated neutrophil chemotaxis. In particular, depending on the concentration and the position of gingipains within the biofilm, these enzymes can exert opposing effects. C3, C5, and IL-8 are degraded at high gingipain concentration or by gingipains associated with bacterial cells or vesicles thus inhibiting pro-inflammatory responses and protecting bacteria from elimination. In contrast, low levels of soluble Arg-specific gingipains activate C5 and C3 by limited proteolysis that results in the generation of C5a and C3a anaphylatoxins. Furthermore, under such circumstances, gingipains can selectively cleave IL-8 generating a truncated, hyperactive IL-869aa variant (written in red) acting in concert with C5a and C3a in order to excessively activate neutrophil pro-inflammatory responses. Additionally, the secreted penta-acylated LPS variant diminishes neutrophil apoptosis which delays the resolution of inflammation Together, these events strongly contribute to the inflammatory tissue destruction observed in periodontitis and to excessive bleeding, providing P.g. and bystander bacteria with access to nutritional resources.](fcimb-07-00197-g0003){#F3}

On top of acylation, *P. gingivalis* can change the phosphorylation status of lipid A (Rangarajan et al., [@B107]). Similarly to other Gram-negative bacteria, *P. gingivalis* synthesizes lipid A that initially contains two phosphate groups at the di-glucosamine backbone. However, dephosphorylation of *P. gingivalis* lipid A can facilitate its deacylation and subsequently manipulate neutrophil responses.

It is a well-documented innate immunity paradigm that LPS is recognized by Toll-like receptor 4 of the host innate immune system, which triggers pro-inflammatory cytokine production and promotes bacteria elimination (Murdock and Nunez, [@B92]; Figure [1](#F1){ref-type="fig"}). While it is true for the LPS of most Gram-negative species, *P. gingivalis*-derived LPS is also a potent activator of TLR2 (Darveau et al., [@B24]). Importantly, this degenerative manipulation of TLR signaling separates pathogen phagocytosis from neutrophil inflammatory response (Figure [3](#F3){ref-type="fig"}). This pathologic effect was achieved by the induction of a cross-talk between the complement receptor C5aR and TLR2, which inhibited the TLR-2-MyD88 signaling pathway and activated an alternative TLR2-Mal-PI3K pathway *in vivo* (Liang et al., [@B74]; Maekawa et al., [@B80]). The authors reported that the ability to activate TLR2 signaling had a protective effect not only toward *P. gingivalis*, but also toward bystander bacteria, otherwise susceptible to bacterial killing. These studies revealed the molecular mechanism of TLR signaling manipulation by *P. gingivalis*, which clearly contributes to the persistence of dysbiotic microbial communities and drives chronic inflammation in periodontal disease (Hajishengallis and Lambris, [@B46]).

Neutrophil apoptosis and subsequent uptake by macrophages, referred to as efferocytosis, is among the key processes leading to the resolution of inflammation. Therefore, neutrophil resistance to cell death and diminished efferocytosis may additionally contribute to the chronic inflammation and collateral tissue damage observed in periodontal disease (Hiroi et al., [@B56]; Zaric et al., [@B135]). Indeed, neutrophils exhibited an impaired immune tolerance to *P. gingivalis* endotoxin. Stimulation with penta-acylated dephosphorylated LPS, the most potent and prevalent endotoxin isoform of *P. gingivalis*, led to continued IL-8 secretion upon secondary exposure, but inhibited TNF-α production. Interestingly, observed results were in contrast to the effect elicited by *E. coli*-derived lipopolisaccharide, which abolished the production of both cytokines upon repeated treatment (Bainbridge et al., [@B6]; Berezow et al., [@B10]). This deregulated inflammatory response to *P. gingivalis* LPS resulted in enhanced neutrophil migratory potential while apoptosis was inhibited as identified by reduced caspase-3 activity (Bainbridge and Darveau, [@B5]; Reife et al., [@B109]; Zaric et al., [@B135]; Figure [3](#F3){ref-type="fig"}). Additionally, not only LPS and lipid A, but also capsular polysaccharide isolated from three different *P. gingivalis* strains (HG-184, A7A1--28, and 381) diminished human or murine PMNs cell death in a time- and dose-dependent manner (Hiroi et al., [@B56]; Preshaw et al., [@B104]) that was not influenced by IL-10 treatment (Murray and Wilton, [@B93]). However, taking into account that *P. gingivalis* endotoxin may engage TLR2 instead of TLR4, this may account for its inhibitory effect on apoptosis (Bainbridge and Darveau, [@B5]; Murray and Wilton, [@B93]). This is particularly important due to the fact that *P. gingivalis* LPS can penetrate gingival tissues and consequently can exert a broad impact toward all immune cells in the periodontium and affect their responses to all bacteria present within the biofilm (Schwartz et al., [@B114]). Therefore, manipulation of PMN apoptosis results in an accumulation of long-lived and fully active neutrophils in the inflamed periodontium, which may contribute to the development and progression of periodontal disease.

These studies provided the molecular evidence that changes in the *P. gingivalis* endotoxin structure influence its binding affinity to TLR4. This selectively affects downstream signaling in order to evade antibacterial responses and sustain inflammation. Collectively, LPS modifications depend on the microenvironment and exert opposing actions on the host immune system. This ensures access to nutrient resources and can potentially protect the entire microbial community from TLR-mediated immune responses.

PMNs deregulation by gingipains
-------------------------------

Gingipains are major cysteine proteases, which are either membrane-bound or secreted and they account for 85% of the total proteolytic activity of *P. gingivalis* (Potempa et al., [@B100]). Based on their specificity, they are divided in two groups, namely arginine-specific (RgpA and RgpB) and lysine-specific (Kgp; Potempa et al., [@B101]). Working in concert, gingipains exhibit trypsin-like activity and can cleave many host components, such as the extracellular matrix, cytokines, immunoglobulins, or complement factors (Guo et al., [@B43]). However, these proteases are not merely responsible for an indiscriminate degradation of proteins, but show a large degree of specificity in action that accounts for much of *P. gingivalis* resistance to host antibacterial strategies (Bostanci and Belibasakis, [@B15]). Gingipains are able to override host defense mechanisms, such as antibody opsonization, complement system activation, or pro-inflammatory signaling, which ensures this periodontopathogen\'s exceptional resistance to the bactericidal activity of the human serum and the killing potential of neutrophils (Figure [3](#F3){ref-type="fig"}).

Opsonization by natural or acquired antibodies is an important protective feature of innate and adaptive immune response and facilitates phagocytosis of invading bacteria. However, gingipain K (Kgp) has the unique ability to cleave IgG1 and IgG3 at the hinge region, thus separating the antigen binding Fab fragment from the effector Fc fragment of immunoglobulins. This activity was observed not only *in vitro* using isolated IgGs or human plasma, but it was also detected *in vivo* in gingival crevicular fluid (GCF). Consequently, treatment of patient serum samples with Kgp inhibited *P. gingivalis* opsonization and subsequent phagocytosis by neutrophils (Kobayashi et al., [@B66]; Guentsch et al., [@B41]; Vincents et al., [@B127]). Therefore, lysine-specific gingipain suppresses IgG-mediated opsonization and *P. gingivalis* phagocytosis, which contributes to pathogen persistence.

Gingipains can also influence the host innate immune response by a manipulation of signaling dependent on the TREM (Triggering Receptor Expressed on Myeloid cells) or PAR (Protease-Activated Receptors) families of cell receptors. TREM-1 receptor belongs to the immunoglobulin family and is involved in the amplification of pro-inflammatory cytokines production as well as regulation of apoptosis. It was reported that gingipains increased the expression of TREM-1 on neutrophils, which resulted in an elevated production of IL-8. Interestingly, depending on gingipain specificity, authors noted opposing biological effects. Arg-specific gingipains were capable of shedding a soluble TREM-1 (sTREM-1) from the PMNs surface, while Lys-specific gingipains were degrading TREM-1 (Bostanci and Belibasakis, [@B14]; Bostanci et al., [@B16]).

Gingipains were also shown to deregulate PAR signaling in neutrophils, gingival fibroblasts, epithelial cells, and T lymphocytes. In particular, Rgps were able to activate PAR2, a G-protein-coupled transmembrane receptor expressed, among others, on neutrophils. Rgps-mediated PAR2 activation enhanced the biosynthesis of prostaglandin E2, IFN-ɤ, IL-1β, and IL-6, which led to accelerated alveolar bone loss in experimentally-induced periodontitis in mice. Therefore, induction of PAR expression by gingipains is designed to sustain inflammation in *P. gingivalis*-infected periodontium (Lourbakos et al., [@B77], [@B78]; Bostanci and Belibasakis, [@B15]). Importantly, authors also reported an elevated expression of PAR2 on neutrophils from periodontitis patients, which indicated that deregulated PAR2 expression may contribute to periodontal inflammation severity (Holzhausen et al., [@B58], [@B57]). Therefore, differential regulation of TREM-1 or PAR2 signaling by gingipains is designed to manipulate the host innate immune responses and contributes to chronic periodontal inflammation.

Additionally, gingipains were also shown to exploit IL-8 signaling in order to sustain inflammation, deregulate neutrophil chemotaxis and eventually inhibit bacterial elimination. Interleukin 8 (IL-8) is a chemokine known as a neutrophil chemotactic factor orchestrating many PMNs bactericidal activities, such as phagocytosis, respiratory burst, production of anti-bacterial enzymes, and pro-inflammatory cytokines. *P. gingivalis* LPS is able to induce the secretion of IL-8~72aa~ and IL-8~77aa~ variants from immune and non-immune cells, respectively. While the first variant is very potent in priming neutrophils, the latter needs to be truncated on the N-terminus to elicit full activity. This functional and structural diversity of IL-8 is exploited by *P. gingivalis*, which can manipulate IL-8 signaling depending on the stage of infection, gingipain concentration as well as the proximity of the cytokine to the bacterial plaque (Figure [3](#F3){ref-type="fig"}). Specifically, Arg- or Lys-gingipains can diminish IL-8~72aa~ activity and inhibit neutrophil chemotaxis as well as ROS production induced by fMLP during initial stages of infection, thus significantly contributing to a local chemokine paralysis. On the contrary, during later stages of *P. gingivalis* infection, the limited proteolysis of IL-8~77aa~ by R- and K-gingipains in the presence of fMLP resulted in the generation of truncated hyperactive IL-8~69aa~ variant, which enhanced PMNs recruitment and oxygen-dependent bacterial elimination (Darveau et al., [@B22]; Dias et al., [@B28]). Additionally, it was shown that enzymes associated with the bacterial outer-membrane blebs (vesicles) degrade and inactivate this chemokine, whereas soluble gingipains were able to process IL-8~77aa~ into the hyper-active variant (Mikolajczyk-Pawlinska et al., [@B89]). Of note, Arg-specific gingipains interfere also with TNF-α signaling by degrading the soluble as well as membrane-bound forms of this cytokine (Mezyk-Kopec et al., [@B88]), which attenuated host immune response and neutrophil recruitment, both especially important during initial stages of *P. gingivalis* infection.

Also, various complement components strongly regulate PMNs activity as these cells constitutively express several complement receptors, such as CR1 (CD35), CR3 (CD11b/CD18, Mac-1), CR4 (CD11c/CD18, Mac-1), or CR5 receptors. Engagement of complement receptors activates many different signaling pathways and triggers neutrophil migration, phagocytosis, degranulation, intracellular killing, or ROS production (Krauss et al., [@B70]; Hajishengallis et al., [@B51]). Not surprisingly, another strategy of immune evasion employed by *P. gingivalis* is the inactivation of complement factors (Figure [3](#F3){ref-type="fig"}). This periodontopathogen produces high quantities of gingipains targeting these fundamental complement-mediated innate immune responses (Popadiak et al., [@B98]). In particular, RgpA can precisely cleave C3 and C5 to produce active C3b and C5a, the latter being an anaphilatixin, strongly promoting neutrophil recruitment to the gingiva (Wingrove et al., [@B132]). Actually, gingipains have been shown to have complex, "biphasic" effects on the complement system. At low concentrations of gingipains, which mimic early infection stages, they precisely cleave C3 and C5 and generate active C3a and C5a, respectively. In turn, at high concentrations or at deeper gingival localization, where the biofilm resides, they inhibit the complement pathway. This indicates that at the beginning of bacterial invasion, gingipains enhance inflammation in order to increase nutrients supply, while at advanced stages of periodontal disease they inactivate the complement cascade, which is designed to protect *P. gingivalis* and bystander bacteria from the bactericidal activity of the human serum and neutrophil killing (Popadiak et al., [@B98]; Potempa and Pike, [@B99]).

Moreover, Lys-specific gingipain was shown to block C5a-mediated anti-microbial activity by cleaving C5aR and abolishing myeloperoxidase release by neutrophils (Jagels et al., [@B62],[@B63]). Interestingly, membrane-bound RgpA can capture complement inhibitor C4BP on *P. gingivalis* surface, which abolishes membrane complement attack (MAC; Potempa et al., [@B102]). Furthermore, gingipains were also shown to interfere with the clotting cascade by degradation of fibrinogen. Especially Kgp increased bleeding tendency at the site of infection and prolonged inflammation (Imamura et al., [@B60], [@B61]; Rapala-Kozik et al., [@B108]).

This data proved that *P. gingivalis* represents a periodontal pathogen, which employs different strategies to gain access to nutrient resources and overcome neutrophil-mediated killing. Not only endogenous host enzymes, but also gingipains mediate periodontal tissue breakdown. Moreover, gingipains, which are found at very high concentrations in periodontal pockets, deregulate the complement cascade, opsonization by immunoglobulins and receptor signaling, collectively leading to increased vascular permeability and bleeding. These effects increase the availability of hemin required for bacterial growth and facilitate the spreading of the pathogen. Depending on the stage of infection, position within the biofilm and specific circumstances, this periodontopathogen can either promote or prevent such activities as complement activation, neutrophil recruitment and inflammatory response. However, observed *in vitro* suppression of inflammatory responses, which manipulate neutrophils infiltration to the periodontium at the very early stages of *P. gingivalis* colonization was not observed *in vivo* during analysis of mouse models of periodontitis. However, it is difficult to establish *in vivo* relevant *in vitro* systems as either cell lines or isolated primary neutrophils are separated from their normal environment. On one hand, *in vitro* approaches allow to study molecular mechanisms in a very precise and controlled manner. On the other hand, *in vitro* work simplifies the system under study. Therefore, conclusions based on *in vitro* approaches or mouse models will be ultimately verified by clinical trials involving periodontitis patients.

Collectively, this compartmentalization of pro- and anti-inflammatory responses protects *P. gingivalis* from elimination and fuels the inflammation in distal positions from bacterial plaque, which clearly contributes to inflammatory tissue damage observed in patients suffering from the periodontal disease.

PMNs deregulation by RBR
------------------------

*P. gingivalis* expresses a non-haem iron protein called rubrerythrin (Rbr) in order to avoid oxidative stress and gain protection from reactive oxygen and nitrogen species. Rbr-positive *P. gingivalis* was shown to be more resistant to neutrophil killing, which enabled colonization of the periodontal tissues. Moreover, this virulence factor increased the mobilization and activation of neutrophils which was indispensable for the establishment of inflammation and contributed to greater tissue damage *in vivo* (Mydel et al., [@B94]). These results suggest that the host respiratory burst is manipulated by rubrerythrin in order to provoke inflammation which, paradoxically, promotes *P. gingivalis* survival.

PMNs deregulation by PPAD
-------------------------

*P. gingivalis* peptidyl arginine deiminase (PPAD) is another enzyme unique to *P. gingivalis*, which converts proteins Arg residues, usually present at the carboxy terminus, into citrulline (McGraw et al., [@B87]). This modification is implicated in the development of rheumatoid arthritis. However, it was also shown that C5a citrullination reduced the chemotactic and proinflammatory potential of this anaphylatoxin (Maresz et al., [@B81]; Bielecka et al., [@B11]; Koziel et al., [@B68]). Therefore, modifications of host proteins by PPAD represent another manipulative strategy designed to protect *P. gingivalis* and bystander bacteria from neutrophil-mediated killing.

PMNs deregulation by fimbriae
-----------------------------

Fimbriae, also called pili, are proteinaceous appendages on the bacterial outer surface, which promote both adhesion to and invasion of the host cells (Enersen et al., [@B33]). In order to colonize the subgingival region, *P. gingivalis* utilizes two types of fimbria, namely long, composed of the FimA protein, and short, or minor, which consists of the Mfa protein. However, fimbriae do not only facilitate bacterial invasion, but also manipulate neutrophil responses. Challenge of PMNs with FimA, a main structural protein of the *P. gingivalis* long fimbriae, resulted in an increased release of the pro-inflammatory cytokine IL-8 and enhanced fibrinogen binding, which could be further augmented by additional stimulation with fMLP (Sahingur et al., [@B113]). Detailed analysis of neutrophil signaling revealed that *P. gingivalis* fimbriae activated TLR2 signaling by employing CD14 and PI3K. This, in turn, induced activation in neutrophils of CD11b-CD18 (also called Mac-1 or CR3) integrins (Harokopakis and Hajishengallis, [@B54]), which are the most abundant integrin type. Usually, Mac-1 engagement trigger inside-out signaling, resulting in inflammatory and antibacterial responses, such as leukocyte adhesion, transmigration, production of inflammatory cytokines, and phagocytosis (Ehlers, [@B31]). However, activation of CR3 by *P. gingivalis* was reported to facilitate the invasion and colonization of macrophages, which subsequently served as an intracellular bacterial reservoir. Therefore, it would be interesting to investigate whether similar mechanisms are employed to corrupt PMNs. Collectively, already published results undoubtedly show that *P. gingivalis* fimbriae strongly manipulate neutrophil signaling in order to prolong a nutritionally favorable inflammatory response and promote bacterial persistence.

Conclusions and future directions {#s6}
=================================

Neutrophil homeostasis in the periodontium is ensured by a balance between neutrophil migration to the site of infection, anti-bacterial and pro-inflammatory response, and finally the clearance of apoptotic PMNs during the resolution of inflammation. However, excessive neutrophil recruitment to the periodontium and their hyper-activation arises as a novel mechanism strongly contributing to the development and progression of periodontal disease. Different *P. gingivalis* virulence factors corrupt many neutrophil functions in order to sustain inflammation, gain access to nutrient resources and ensure protection from killing. This suggests that neutrophil contribution to the progression of periodontitis might not only be related to defective elimination of bacteria, but additionally involve a deregulation of immune tolerance, neutrophil apoptosis and mechanisms driving resolution of inflammation. However, depending on the specific circumstances and the stage of bacterial infection, the manipulation of PMNs might actually lead to opposing effects, either pro- or anti-inflammatory. Therefore, future research might discover the link between regulatory defects in anti-bacterial or effector neutrophil functions and the progression of chronic periodontal disease. A better molecular understanding of periodontitis-associated neutrophil dysfunctions due to their manipulation by *P. gingivalis* could be used as a potential targeted therapy in patients.
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